MedPath

The study of Siddha drug Sirupanchamoola kiyazham, Thirumeni Ennai and Varmam therapy in patients having Saganavadam (Cervical Spondylosis)

Phase 2
Conditions
Health Condition 1: M472- Other spondylosis with radiculopathy
Registration Number
CTRI/2019/06/019695
Lead Sponsor
Government Siddha Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Complain about dull pain behind the neck in the area of trapezius

Radiating pain to the upper limbs

Numbness and weakness in arms, hands and fingers

Giddiness

Muscle spasms in neck and shoulders

Exclusion Criteria

Trauma

Cervical rib

Ankylosing spondylosis

Cardiac disease

Fracture

Adhesive capsulitis

Caries spine

Patient with any other serious systemic illness

Malignancy

Pregnancy and Lactation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Outcome of the treatment is assessed by neck disability index, Nurick Classification scoring system, chin test, spurling test, range of movementTimepoint: 48 Days
Secondary Outcome Measures
NameTimeMethod
Secondary outcome is assessed by comparing the safety parameters before and after treatmentTimepoint: 48 Days
© Copyright 2025. All Rights Reserved by MedPath